Cargando…

Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?

Detalles Bibliográficos
Autores principales:	Bosas, Paulius, Zaleskis, Gintaras, Pasukoniene, Vita, Jankevicius, Feliksas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466421/ https://www.ncbi.nlm.nih.gov/pubmed/32873304 http://dx.doi.org/10.1186/s12967-020-02496-5

Ejemplares similares

Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
por: Bosas, Paulius, et al.
Publicado: (2021)

Letter to the Editor Re: Yamamoto R, Sugiura T, Ashida R, Ohgi K, Yamada M, Otsuka S, and Uesaka K. Prognostic value of carbohydrate antigen 19‐9 and the surgical margin in extrahepatic cholangiocarcinoma. Ann Gastroenterol Surg. 2022; 6:307–315
por: Zaleskis, Gintaras, et al.
Publicado: (2023)

Do the benefits of being a smoker hint at the existence of PD-1/PD-L1 sensitizers for patients on single-agent immunotherapy?
por: Zaleskis, Gintaras, et al.
Publicado: (2021)

Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention
por: Zaleskis, Gintaras, et al.
Publicado: (2020)

Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design
por: Moghnieh, Rima, et al.
Publicado: (2022)

Prostate cancer solitary metastasis to anal canal: case report and review of literature
por: Dulskas, Audrius, et al.
Publicado: (2019)

Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging
por: Bakavicius, Arnas, et al.
Publicado: (2019)

Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
por: Barisiene, Marija, et al.
Publicado: (2020)

The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival
por: Bakavičius, Arnas, et al.
Publicado: (2020)

Frequent down-regulation of ABC transporter genes in prostate cancer
por: Demidenko, Rita, et al.
Publicado: (2015)

The utility of urine-circulating miRNAs for detection of prostate cancer
por: Stuopelyte, Kristina, et al.
Publicado: (2016)

Immunophenotype Lymphocyte of Peripheral Blood in Patients with Psoriasis
por: Karamehic, Jasenko, et al.
Publicado: (2014)

Treatment of recurrent stress urinary incontinence in women: comparison of treatment results for different surgical techniques
por: Cerniauskiene, Ausra, et al.
Publicado: (2014)

LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer
por: Vezelis, Alvydas, et al.
Publicado: (2021)

Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy
por: Vėželis, Alvydas, et al.
Publicado: (2021)

Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies
por: MacLean, Carol M., et al.
Publicado: (2023)

Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence
por: Daniunaite, Kristina, et al.
Publicado: (2021)

Immunophenotyping of Peripheral Blood and Bone Marrow Cells by Flow Cytometry
por: Akanni, EO, et al.
Publicado: (2006)

Immunophenotype of Peripheral Blood Lymphocytes in Dogs with Inflammatory Bowel Disease
por: Galler, A., et al.
Publicado: (2017)

Letter to the Editor—American Journal of Men’s Health: Prostatitis
por: Johnson, Ericka
Publicado: (2021)

Letter to the Editor [Letter]
por: Félix, Sylvie
Publicado: (2021)

Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer
por: Ryan, Stephen T., et al.
Publicado: (2020)

Bosniak category III renal lesions: likelihood of malignancy based on computed tomography findings
por: Bielskienė, Neringa, et al.
Publicado: (2017)

Decreased expression of MT1E is a potential biomarker of prostate cancer progression
por: Demidenko, Rita, et al.
Publicado: (2017)

Immunophenotyping of Sheep Paraffin-Embedded Peripheral Lymph Nodes
por: Melzi, Eleonora, et al.
Publicado: (2018)

Clinical Significance of ADAMTS19, BMP7, SIM1, and SFRP1 Promoter Methylation in Renal Clear Cell Carcinoma
por: Kubiliute, Raimonda, et al.
Publicado: (2021)

Evaluation of Renal Function after Partial Nephrectomy and Detection of Clinically Significant Acute Kidney Injury
por: Makevičius, Jurijus, et al.
Publicado: (2022)

Letter to the Editor
Publicado: (1997)

Letter to the Editor
por: Wölner-Hanssen, Pål
Publicado: (1996)

Letter to The Editor
por: Goldring, J. R.
Publicado: (1989)

Letters to the Editor
Publicado: (1998)

Letter to the Editor
por: Pouwer, Frans
Publicado: (2008)

Letters to the Editor
por: Levine, Elliott M.
Publicado: (2001)

Letter to the editor
por: Kanna, Balavenkatesh, et al.
Publicado: (2005)

Letters to the Editor
por: McKenna, Michael J.
Publicado: (1979)

Letter to the editor
por: Rosival, Viktor
Publicado: (2005)

Letter to the Editor
por: Clair, R. E. Wright-St.
Publicado: (1973)

Letters to the Editor
por: Hinners, Thomas A.
Publicado: (1975)

Letters to the Editor
por: Piver, Warren T.
Publicado: (1975)

Letters to the Editor
por: Johnson, Donald E.
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_4l8m97g0vtolpie9p1oef0i5i0